These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication. Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669 [TBL] [Abstract][Full Text] [Related]
3. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance. Deakyne JS; Malecka KA; Messick TE; Lieberman PM J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406 [TBL] [Abstract][Full Text] [Related]
4. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter. Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517 [TBL] [Abstract][Full Text] [Related]
5. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma. Zhang J; Jia L; Tsang CM; Tsao SW Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. Sivachandran N; Sarkari F; Frappier L PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293 [TBL] [Abstract][Full Text] [Related]
7. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. Cao JY; Mansouri S; Frappier L J Virol; 2012 Jan; 86(1):382-94. PubMed ID: 22013061 [TBL] [Abstract][Full Text] [Related]
8. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus Mei Y; Messick TE; Dheekollu J; Kim HJ; Molugu S; Muñoz LJC; Moiskeenkova-Bell V; Murakami K; Lieberman PM J Virol; 2022 Sep; 96(17):e0094922. PubMed ID: 36037477 [TBL] [Abstract][Full Text] [Related]
9. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers. Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012 [TBL] [Abstract][Full Text] [Related]
10. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528 [TBL] [Abstract][Full Text] [Related]
11. A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Do NV; Ingemar E; Phi PT; Jenny A; Chinh TT; Zeng Y; Hu L Virus Res; 2008 Mar; 132(1-2):15-24. PubMed ID: 18096263 [TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections. Malik-Soni N; Frappier L J Virol; 2012 Jun; 86(12):6999-7002. PubMed ID: 22496234 [TBL] [Abstract][Full Text] [Related]
13. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Messick TE; Smith GR; Soldan SS; McDonnell ME; Deakyne JS; Malecka KA; Tolvinski L; van den Heuvel APJ; Gu BW; Cassel JA; Tran DH; Wassermann BR; Zhang Y; Velvadapu V; Zartler ER; Busson P; Reitz AB; Lieberman PM Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842315 [TBL] [Abstract][Full Text] [Related]
14. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription. Liu CD; Lee HL; Peng CW J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781 [TBL] [Abstract][Full Text] [Related]
15. EBNA1. Frappier L Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370 [TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism. Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427 [TBL] [Abstract][Full Text] [Related]
18. Role of EBNA1 in NPC tumourigenesis. Frappier L Semin Cancer Biol; 2012 Apr; 22(2):154-61. PubMed ID: 22206863 [TBL] [Abstract][Full Text] [Related]
19. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. Chen JN; Zhang NN; Jiang Y; Hui DY; Wen ZJ; Li HG; Ding YG; Du H; Shao CK PLoS One; 2012; 7(11):e50084. PubMed ID: 23189182 [TBL] [Abstract][Full Text] [Related]
20. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells. Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]